Security key
G1281K114
Silexion Therapeutics Corp - Ordinary shares, par value $0.135 per share (SLXNW)
CUSIP: G1281K114
Q3 2026 13F Holders as of 30 Sep 2026
- Security type / class
- Equity / Ordinary shares, par value $0.135 per share
- Total 13F shares
- 32,500
- Total 13F value
- $306
- Share change
- 0
- SEC-reported price per share
- $0.01
- Number of holders
- 1
Report period
Q3 2026
Institutions
1
Top holders
1
SLXNW full security history
Ownership snapshot
Full 13F holder table
Silexion Therapeutics Corp SEC filings
Silexion Therapeutics Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP G1281K114
Recent filing periods:
Ownership snapshot
Top reported holders of SLXNW - Silexion Therapeutics Corp - Ordinary shares, par value $0.135 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Moringa Sponsor, LP
Disclosed value leader
Ilan Levin
Comparable rows
8/15
Latest evidence
18 Sep 2026
13D/G
13F
3/4/5
Lead comparable stake: 18%
7 rows are not safely comparable across share classes.
13D/G row: Moringa Sponsor, LP
Showing 1-6 of 15 holder rows.
Quick read
Moringa Sponsor, LP leads the comparable SEC ownership view at 18%.
8 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Moringa Sponsor, LP's linked filing trail.
Comparable ownership
Top 5
Moringa Sponsor, LP
18%
Lincoln Alternative Strategies LLC
6.2%
INTRACOASTAL CAPITAL, LLC
5%
Lind Global Fund III LP
5%
Orca Capital AG
4.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Moringa Sponsor, LP |
13D/G
|
18%
Reported 13D/G
· 18 Sep 2026
|
$820,704
1,954,056 shares
|
+$236,136 | 18 Sep 2026 |
| Lincoln Alternative Strategies LLC |
13D/G
|
6.2%
Reported 13D/G
· 12 Sep 2025
|
$115,500
131,250 shares
|
$0 | 12 Sep 2025 |
| INTRACOASTAL CAPITAL, LLC |
13D/G
Mitchell P. Kopin
|
5%
Reported 13D/G
· 11 Aug 2026
|
$120,484
286,866 shares
|
-$16,016 | 11 Aug 2026 |
| Lind Global Fund III LP |
13D/G
|
5%
Reported 13D/G
· 31 Mar 2026
|
$272,042
212,500 shares
|
$0 | 31 Mar 2026 |
| Orca Capital AG |
13D/G
|
4.9%
Reported 13D/G
· 11 Sep 2025
|
$802,137
109,432 shares
|
$0 | 11 Sep 2025 |
| CVI Investments, Inc. |
13D/G
|
4.9%
Reported 13D/G
· 31 Mar 2025
|
$424,574
456,531 shares
|
+$109,304 | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
32,500
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q2 2026 Across Filers
Q2 2026 holders
18
Q3 2026 holders
1
Holder diff
-17
| Investor | Q2 2026 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend